Autophagy is commonly described as a cell survival mechanism and has been implicated in chemo-and radioresistance of cancer cells. Whether ionizing radiation induced autophagy triggers tumor cell survival or cell death still remains unclear. In this study the autophagy related proteins Beclin1 and ATG7 were tested as potential targets to sensitize colorectal carcinoma cells to ionizing radiation under normoxic, hypoxic and starvation conditions. Colony formation, apoptosis and cell cycle analysis revealed that knockdown of Beclin1 or ATG7 does not enhance radiosensitivity in HCT-116 cells. Furthermore, ATG7 knockdown led to an increased survival fraction under oxygen and glutamine starvation, indicating that ionizing radiation indeed induces autophagy which, however, leads to cell death finally. These results highlight that inhibition of autophagic pathways does not generally increase therapy success but may also lead to an unfavorable outcome especially under amino acid and oxygen restriction.
Introduction
Autophagy is a process conserved in evolution which is supposed to recycle damaged proteins and cell organelles. It is further divided into macro-, micro-and chaperone-mediated autophagy, each of this processes involving different effector proteins, substrates and signaling pathways [1] . Macroautophagy (afterwards referred to as autophagy) describes breakdown and recycling of cell organelles (e.g. mitochondria, cell membrane, and cytoplasm) through lysosomal degradation [2] .
Beclin1 is crucial for recruiting autophagic proteins to preautophagosomal structures (PAS). Autophagy substrates are then identified through ubiquitin recognition sites by cargo proteins like p62/SQSTM which then bind to MAP1LC3A/B (=LC3). The LC3-p62-substrate complex is then recruited to the autophagosome where the substrates are degraded through acidification by lysosomal fusion [3, 4] . The autophagosome formation depends on the ubiquitin-like protein LC3-I and its conjugation to phosphatidylethanolamine (PE) resulting in LC3-II. This reaction is based on the function of ubiquitin E1-like activity of autophagy-related 7 (ATG7), the E2-like activity of ATG3, and the E3-like activity of the ATG5-ATG12-ATG16L1 complex [5] . Basal autophagy has been demonstrated in almost every tissue and contributes to cellular homeostasis by degradation of outdated and damaged cellular components. Severe stress situations like hypoxia, nutrient deficiency and genetic aberrations increase basal autophagy which allows the cell to regain homeostasis or, however, leads to cell death [6, 7] .
Cancer cells face a number of autophagy-inducing conditions through their high proliferation rate, lack of nutrients, genetic instability and expansion of protein translation. Indeed, autophagy has been linked to suppression of cancer development but, on the other hand, drives progression and therapy resistance by maintaining cellular homeostasis in fully evolved tumors [8] [9] [10] . Therefore, targeting autophagy has been proposed to improve clinical outcome and prevent therapy resistance in patients suffering from malignancies [11, 12] . However, evidence for therapeutic success is rare and still investigated in numerous clinical studies [13] . To date, treating patients with autophagy inhibitors or enhancers is experimental and may also result in an unfavorable outcome.
Considerable effort has been made over the past years to delineate situations where oncologists may reasonably support or suppress autophagy induction in cancer patients, but reliable biomarkers are still lacking [14] . As expertly reviewed recently [15] , LC3 and Beclin1 were tested in different cancer types to assess the connection between expression level and overall survival, but due to limited data and, on some occasions, less than ideal study design this issue still remains ambiguous. Furthermore, tumors bearing RAS mutations have been suggested to be autophagy dependent to maintain adequate energy supply but this objective is still under investigation and discussed controversially [16] [17] [18] .
Ionizing radiation is one of the three major treatment modalities in cancer therapy but often fails to control tumor growth due to development of resistance and dose limiting side effects [19, 20] . Therefore, it is mandatory to identify new target proteins that increase the benefit of treatment. Ionizing radiation has been shown to induce autophagy in vitro and in vivo, but because the consequence of radiation-induced autophagy remains unclear so far [21, 22] , we investigated the effect of ATG7 or Beclin1 depletion in combination with ionizing radiation under hypoxic and starvation conditions in the colorectal cancer cell line HCT-116 (KRAS G13D). Our intention was to delineate whether ionizing radiation induced autophagy favours cell death or survival in colorectal cancer cells and to help clarify whether blocking autophagy displays a rational target to increase cancer cell sensitivity to X-ray treatment.
Material and methods

Antibodies
LC3-antibody was purchased from Novus Biologicals (Littleton, CO). Antibodies against ATG7 and Beclin1 were form Cell Signaling (Frankfurt a. Main, Germany) and used in a dilution from 1:500 to 1:1000. HRP-coupled secondary antibodies against murine or rabbit antibodies were purchased from Dako (Hamburg, Germany).
Cell culture and lentiviral transduction
HCT-116 (ATCC® CCL-247™) cells were cultured in McCoy's 5A medium (Lonza, Basel, Switzerland), HEK293T cells in DMEM High Glucose (Invitrogen, Darmstadt, Germany). Media was supplemented with 10% FBS and 1% penicillin/streptomycin. Lentiviral particles were produced in HEK293T cells and knockdown cells were generated through lentiviral transduction as reported previously [23] . In brief, HCT-116 cells were incubated with 10 lentiviral particles per cell for 24 h. Adherence of the viral particles was increased by addition of 8 µg/ ml polybrene. Selection of transduced cells was performed using 2 µg/ ml puromycin. The knockdown (KD) was induced by incubation with 250 ng/ml doxycycline. shRNA sequence 5′-"GCCTGCTGAGGAGCTCT CCAT"-3' was used for ATG7 knockdown, shRNA sequence 5′-"CTCAA GTTCATGCTGACGAAT"-3′ for Beclin1 knockdown. Glutamine starvation was performed through incubation with McCoy's A5 medium without L-glutamine (Sigma, Missouri, USA).
SDS-Page and Western blotting
Samples were lysed in RIPA buffer (50 mM Tris pH 7.5, 2 mM EDTA, 150 mM NaCl, 1% Nonidet P40, 0.1% SDS, 0.5% sodium deoxycholate and protease/phosphatase inhibitor cocktail (#5872, Cell Signaling)) Samples were prepared in SDS-sample buffer (62,5 mM Tris (pH 7.4) 2% SDS, 3% β-mercaptoethanol, 10% glycerol, 0.25 mg/ml bromophenol blue, 25 mM DTT. Proteins were separated by SDS-Page using 12.5% polyacrylamide gels and were transferred to a PVDF membrane using the Trans-Blot Turbo Blotting System (Bio Rad, München, Germany). The membrane was blocked by incubation in 5% skimmed milk in TBS-T buffer (50 mM Tris/HCL, 150 mM NaCl, 0.1% Tween-20, pH 7.2). Primary antibody solutions were prepared as recommended by the manufacturer and incubated with the PVDF membranes overnight. Secondary HRP-linked antibodies were diluted in 5% skimmed milk in TBS-T and were incubated with the membranes for 1 h the following day. Protein detection was performed with an ECL kit (#34095, Thermo Fisher Scientific, Oberhausen, Germany) and an FX7 chemiluminescence documentation system (Peqlab, Erlangen, Germany).
Colony formation assay (CFA)
Cells were seeded as singletons in rat collagen type I coated 6-well dishes. Knockdown was induced immediately after seeding and the cells were irradiated within the next 24 h. For experiments under hypoxic conditions cells were pre-incubated in 1% O 2 for 4 h prior to irradiation. Irradiation of the cell cultures was performed using an X-ray machine (X-rad 320, PXI) operated at 320 kV, 12.5 mA with a 1.65 mm aluminum filter (dose rate: 3.6 Gy/min). 10 days after seeding the experiment was terminated by cell fixation using 0.25% paraformaldehyde (PFA) for 20 min and 70% ethanol for 10 min. Afterwards the cells were stained with Coomassie brilliant blue (0.1 Coomassie blue, 5% acetic acid, 45% methanol). The dishes were photographed with the FX7 system (Peqlab). Colonies consisting of more than 50 cells were counted using ImageJ. The plating efficiency (PE) was determined in control cells as the number of counted colonies/seeded cells. The survival fraction (SF) was calculated as number of colonies formed after treatment/(cells seeded × PE).
Long time survival assay (LTSA)
Long time survival assays were performed similar to colony formation assays. In contrast to CFA the cells were irradiated 72 h after seeding and knockdown induction. LTSA were used to measure radiosensitivity at the timepoint with lowest target protein levels. Hypoxia as well as glutamine starvation was induced 4 h prior to irradiation.
Caspase-3-assays
Caspase-3-assays were performed in black bottom 96-well plates. 50 µg protein per well were diluted in 50 µl caspase-3 lysis buffer (Tris (pH 7.3) 50 mM, NaCl 150 mM, Nonidet P40 1%). 150 µl caspase-3 substrate buffer (HEPES (pH 7.3) 20 mM, NaCl 100 mM, saccharose (w/ v) 10%, CHAPS (w/v) 0.1%) were added and supplemented with 66 µM acetyl Asp-Glu-Val-Asp 7-amido-4-methylcoumarin (Ac-DEVD-AMC; A1086, Sigma) and 10 mM DTT. Quantification of caspase-3-activity was performed by measuring fluorescence of 7-amino-4-methylcoumarin (AMC) at 430 nm that was released after caspase-3-mediated cleavage of Ac-DEVD-AMC. Repeated measurements were performed every 10 min for 4 h. Bar graphs represent single time point measurements in the linear range of the reaction.
Cell cycle analysis
× 10
4 cells were seeded in 6 well dishes and KD was induced immediately afterwards. After 72 h the cells were transferred to hypoxic incubation (1% oxygen) and/or glutamine starvation for 24 h. Afterwards cells were detached using trypsine-EDTA, nuclei were isolated and stained using hypotonic citrate buffer (0.1% sodium citrate, 0.1% Triton X-100) containing 50 μg/ml propidium iodide (PI). DNA content of at least 10,000 nuclei was measured using FACS-analysis.
Statistical analysis
All results were acquired in at least two independent experiments as triplicates. Statistical analysis was performed with GraphPad Prism 6 using two-way Anova with Bonferroni post-hoc test. Significance is presented as * indicating p < 0.05. Cell lysates were processed for Western blotting as described in the methods section. Efficiency of the lentiviral knockdown was demonstrated using ATG7 or Beclin1 antibodies. LC3 and p62 antibodies were used to detect changes of the autophagic flux. (B) Radiosensitivity was quantified using colony formation assay. Cells were irradiated within 24 h after seeding with 1 and 3 Gy. After treatment, the cells were maintained for 10 days prior to fixation and staining. (C) Apoptosis was measured by caspase-3 activity assay. 24 h after seeding, cells were irradiated with 10 Gy. Caspase-3 activity was quantified after 96 h. (D) Cell cycle distribution was analyzed by PI staining and flow cytometry 96 h after knockdown induction. Groups were compared using two-way Anova and Bonferroni post-hoc test. Statistical significance is presented as * p < 0.05. Graphs show mean +/-SD.
Fig. 2. ATG7 and Beclin1
KD under hypoxic conditions. Experiments in hypoxia (1% O 2 ) followed the same protocol as in normoxic conditions. KD was induced immediately after seeding. The cells were incubated in normoxia overnight before being transferred to hypoxia. (A) Western blotting of LC3 and p62 was used to demonstrate decreased autophagic flux under hypoxic conditions after ATG7 and Beclin1 KD. KD was induced for 96 h. (B) CFA after ATG7 and Beclin1 KD under hypoxic conditions. Cells were incubated in normoxia overnight and were transferred to hypoxia 4 h prior to irradiation. Cells were maintained under hypoxic conditions for 9 d. (C) Caspase-3 assay of ATG7 and Beclin1 depleted cells in 1% O 2. Cells were incubated for 24 h under 21% O 2 and were transferred to hypoxia 4 h prior to irradiation. Cells were maintained under hypoxic conditions for 72 h. (D) Cell cycle analysis of ATG7 and Beclin1 depleted cells under hypoxic conditions. KD was induced for 96 h. After 72 h, the cells were transferred to hypoxia for 24 h. Each experiment was repeated twice and was performed at least in triplicates. Groups were compared using two-way Anova and Bonferroni post-hoc test. Statistical significance is presented as * p < 0.05. Graphs show mean +/-SD.
Results
ATG7 and Beclin1 knockdown under normoxic (21% O 2 = Nox) conditions
Western blot analysis confirmed reduced ATG7 protein levels after lentiviral transduction and knockdown (KD) induction. Decreased conversion of LC3-I to LC3-II indicated impaired autophagic flux after ATG7 depletion. Simultaneously p62 protein levels were increased by KD of ATG7 (Fig. 1A, left panel) . In CFAs, the survival fraction was not significantly decreased by KD of ATG7 alone or in combination with ionizing radiation (Fig. 1B, left panel) . Caspase-3 activity was increased by 20% after ATG7 KD alone and in combination with 10 Gy irradiation, indicating modest apoptotic activity (Fig. 1C, left panel) . Cell cycle analysis demonstrated a 2-fold increase of cells in G2-phase after ATG7 KD (Fig. 1D, left panel) .
Beclin1 protein levels were reduced potently after knockdown induction as shown by Western blot analysis. Beclin1 knockdown surprisingly did not inhibit LC3 conversion and only a small increase of p62 was detectable (Fig. 1A, right panel) . However, when survival was measured by CFA and compared to Beclin1 proficient cells, Beclin1 KD alone decreased survival by 67%, 1 Gy irradiation by 70% and 3 Gy by 58% (Fig. 1B, right panel) . With respect to apoptosis induction, Beclin1 KD alone only marginally increased caspase-3 activity while Beclin1 KD combined with 10 Gy irradiation reduced apoptotic level by 23% (Fig. 1C, right panel) . Beclin1 KD cells did not show any change in cell cycle distribution (Fig. 1D, right panel) .
ATG7 and Beclin1 knockdown under hypoxic conditions (1% O 2 = Hox)
To increase stress and simulate tumor microenvironment, cells were incubated under oxygen limiting conditions. Similar to the normoxic situation, ATG7 KD led to decreased LC3 conversion and accumulation of p62 under 1% O 2 ( Fig. 2A, left panel) . Oxygen deprivation did not change clonogenic survival after ATG7 KD after application of various irradiation doses (0, 1 or 3 Gy) (Fig. 2B, left panel) . ATG7 KD alone did not increase caspase-3 activity whereas 10 Gy irradiation in combination with ATG7 KD increased apoptosis by 28% (Fig. 2C, left panel) . The fraction of the cells in G2-phase was enhanced 2-fold under hypoxic conditions through ATG7 depletion (Fig. 2D, left panel) .
Oxygen deprivation together with Beclin1 KD again did not inhibit LC3 conversion and only led to a minor induction of p62 ( Fig. 2A, right  panel) . In CFAs, Beclin1 KD led to survival of approximately 50% less cells as compared to uninduced cells independent of the irradiation dose. Only in cells which were not irradiated, means were significantly different (Fig. 2B, right panel) . Caspase-3 activity remained unchanged after Beclin1 KD when the cells were not irradiated. However, in combination with 10 Gy irradiation caspase-3 activity was reduced by 16% (Fig. 2C, right panel) . While Beclin1 KD did not show any effect on cell cycle progression under normoxia, there was a minor increase in the G1 cell population under hypoxia (Fig. 2D, right panel) .
Glutamine starvation under normoxic (21% O 2 ) conditions
To enhance cellular dependency on autophagy, cells were cultured in glutamine deprived media to increase autophagic flux. Indeed, glutamine starvation led to increased LC3-I to LC3-II conversion and decreased p62 protein levels under normoxic conditions. Knockdown of ATG7 led to reduced LC3 conversion and accumulation of p62 in the presence of glutamine as well as after glutamine starvation, thus confirming inhibition of autophagic flux (Fig. 3A, left panel) . To ensure lowest target gene expression at the time of radiation treatment, we modified the CFA by increasing doxycycline incubation from 24 to 72 h prior to radiation treatment (referred to as long term survival assay (LTSA)). In LTSA, ATG7 KD did not show a significant change in survival fractions which demonstrates that increasing the incubation time with doxycycline does not affect survival per se (Fig. 3B left  panel) . Upon glutamine starvation, however, ATG7 KD increased the survival fraction irrespective of the radiation dose, although statistical significance was not verified in this experiment (Fig. 3C, left panel) . Glutamine starvation in ATG7 KD cells did not affect cell cycle progression (Fig. 3D, left panel) .
Glutamine starvation increased LC3-conversion in wildtype and in Beclin1-depleted cells, indicating enhanced autophagic flux (Fig. 3A,  right panel) . p62 was only decreased in wildtype cells after glutamine starvation while deficiency of Beclin1 led to constant levels of p62, indicating impaired autophagic flux in Beclin-deficient cells (Fig. 3A,  right panel) . In LTSA with non-starved cells, Beclin1 KD showed a reduction of survival by 41% without irradiation, by 36% after 1 Gy and by 31% after 3 Gy (Fig. 3B, right panel) . Comparable results were obtained by CFA as shown in Fig. 1B . This effect was even more pronounced after glutamine starvation: without irradiation, survival was reduced by 72%, after 1 Gy by 55% and after 3 Gy by 47% (Fig. 3C,  right panel) . These results highlight the importance of Beclin1 under amino acid starvation. Beclin1 KD did not alter cell cycle distribution after glutamine starvation (Fig. 3D, right panel) .
Glutamine starvation under hypoxic (1% O 2 ) conditions
When we combined hypoxia and glutamine starvation, ATG7 KD led to similar effects on LC3 conversion and p62 levels as under normoxic conditions (compare Fig. 4A and Fig. 3A) . Unexpectedly, LTSA showed increased survival after ATG7 KD under oxygen starvation and ionizing radiation, although significance was only reached after 1 Gy irradiation (Fig. 4B, left panel) . Survival was increased by 11% without irradiation, after application of 1 Gy survival was increased by 24% and after 3 Gy by 15% (Fig. 4B, left panel) . Hypoxia together with glutamine deprivation and ATG7 knockdown increased the survival advantage even further. Survival was significantly increased by 27% without irradiation, by 25% after 1 Gy and by 26% after 3 Gy (Fig. 4C, left panel) . ATG7 KD showed no changes in cell cycle progression after glutamine and oxygen starvation (Fig. 4D, left panel) .
Under hypoxic conditions Beclin1 KD again led to a moderate increase in LC3 conversion and also to enhanced p62 protein levels. Additionally, LC3 conversion and p62 degradation was enhanced by glutamine deprivation in control and in KD cells (Fig. 4A, right panel) . In LTSA, Beclin1 KD showed significantly decreased survival fraction under 1% oxygen, which was even more pronounced after glutamine starvation (Figs. 4B and 4C, right panel) . In non-starved cells Beclin1 KD led to decreased survival by 24% without irradiation. Combination of Beclin1 KD with 1 Gy or 3 Gy irradiation decreased survival by 36% and 13%, respectively (Fig. 4B, right panel) . After glutamine starvation Beclin1 KD showed a decreased survival by about 60% independent of the irradiation dose (Fig. 4C, right panel) . Cell cycle analysis displayed a significant increase in G1-phase cells from 49% to 63% after Beclin1 KD, oxygen and glutamine deprivation (Fig. 4D, right panel) .
Discussion
To date, no reliable biomarkers are available to predict the role of autophagy in patient tumors or cancer cells, making it impossible to differentiate in which tumor type autophagy should be inhibited or induced for therapy success. RAS mutated cancer cells were described to be autophagy dependent [24, 25] . In our experiments, HCT-116 cells, which express mutated KRAS (G13D), did not show significant alteration in proliferation, cell death or cell cycle progression after ATG7 depletion, indicating that RAS status does not reliably predict therapy outcome. This is in line with recent findings, describing autophagy as a dispensable mechanism for growth of RAS mutated pancreatic tumor cells [16] .
Upstream targeting of autophagy by silencing of PI3K or Beclin1 inhibits cargo identification and trafficking. Depletion of more downstream components such as ATG5 or ATG7 attenuates autophagosome formation while upstream events remain largely unaffected [13] . Based on our results, we postulate that targeting proteins upstream of the cascade (e.g. Beclin1) is more effective in disrupting cancer cell proliferation than targeting essential autophagy proteins further downstream. In addition, this study raises questions about the general importance of autophagy for tumor cell survival, because upstream inhibition might not only affect autophagy, but also multiple proliferation, cell cycle and apoptosis pathways [26] . In this study, Beclin1 KD, which inhibits autophagy early in the signal cascade, reduced colony formation ability irrespective of environmental conditions that are thought to increase the importance of autophagy. Furthermore, Beclin1 depletion did not fully inhibit autophagic flux as measured by LC3 processing, although the survival fraction was decreased more strikingly when cells were cultured under starvation conditions. This Cells were incubated for 24 h in hypoxic and glutamine starved conditions. Each experiment was repeated twice and was performed at least in triplicates.
Groups were compared using two-way Anova and Bonferroni post-hoc test. Statistical significance is presented as * p < 0.05. Graphs show mean +/-SD.
indicates that the observed phenotype upon Beclin1 KD did not completely depend on autophagy inhibition, but rather on disruption of the complex Beclin1 interactome which can lead to a stimulation of apoptosis and the DNA damage response [26, 27] . Radiation induced autophagy has attracted particular interest, because it occurs in every tumor type irrespective of tumor origin and stage [28] [29] [30] . Some studies indicate that induction of autophagy sensitizes cancer cells to radiotherapy while others propose inhibition to be more beneficial [22, [31] [32] [33] [34] [35] . Studies claiming autophagy inhibition as a promising approach to increase radiation sensitivity were often carried out using hydroxychloroquine [36] [37] [38] . Compared to gene silencing of essential autophagy components, chloroquine treatment does not block autophagosome formation but the acidification and cargo degradation of the mature autophagosome [39] . This might contribute to the differences observed in radiation sensitivity upon chloroquine treatment compared to silencing of ATGs as induced by siRNA. Furthermore, it indicates that the inhibition of autophagosome formation is not as effective as prevention of lysosome acidification in case of tumor control. However, chloroquine still shows antitumor activity in autophagy deficient cells. Therefore it is unlikely that the primary treatment effect of chloroquine occurs through autophagy inhibition alone [16] . In this study, we provide strong evidence that continuous inhibition of autophagy by ATG7 depletion does not increase radiosensitivity of HCT-116 cells. In contrast, ATG7 KD led to a significant survival advantage when autophagy was additionally induced by conditions limiting oxygen and glutamine supply. To our knowledge, these conditions which are intended to simulate tumor microenvironment have not been addressed in irradiation studies so far. The survival benefit in ATG7 KD cells upon starvation strongly suggests that autophagy induced by ionizing radiation triggers cell death rather than promoting cell survival.
Taken together, we propose that drugs targeting the early cargo recognition and transport or the late cargo degradation might be more promising than targeting single ATGs which inhibit autophagosome formation, in particular when nutrients and oxygen are restricted, e.g. during radiotherapy. Unfortunately, the current knowledge of autophagy in cancer cells is confounding, in parts contradictory and seems to vary extensively by minor changes in methodology, choice of cell line, animals or targeted genes [13] . Clinical trials using hydroxychloroquine in combination therapy regimes showed remarkably improved therapy outcome in glioblastomas and other tumors. However, it is questionable in how far autophagy inhibition contributed to the observed survival advantage in patients [40] [41] [42] . As an additional note of caution, Kroemer and colleagues have demonstrated that autophagy is mandatory for immunogenic cell death in vivo and therefore suggest that inhibition will decrease the immune response against the tumor [43] . Therefore, further research is needed to elucidate the autophagy process and to decide under which conditions and at which section of the autophagic cascade an inhibition or induction is desirable for clinical treatment.
